INIS
RADNOSTIX INC
0.00 (0.00%)0.06USD4.2K成交股數31.7M市值–本益比(近四季)2.8股價營收比-26.9%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 2.7M-27% | 2.4M-27% | 2.9M-26% | 3.3M+3% | 3.7M+26% | 3.2M+3% | 3.9M+34% | 3.2M+2% | 2.9M | 3.1M | 2.9M | 3.1M |
| 營業成本 | 1.3M | 1.2M | 1.3M | 1.3M | 1.5M | 1.2M | 1.5M | 1.2M | 1.0M | 1.2M | 1.1M | 1.3M |
| 毛利 | 1.4M-37% | 1.2M-43% | 1.6M-35% | 1.9M-4% | 2.1M+15% | 2.0M+3% | 2.4M+37% | 2.0M+9% | 1.9M | 2.0M | 1.8M | 1.8M |
| 毛利率 | 50.9% | 48.4% | 54.8% | 59.2% | 58.6% | 62.7% | 62.4% | 63.7% | 64.2% | 62.4% | 61.4% | 59.2% |
| 研發費用 | 115K | 149K | 87K | 139K | 103K | 107K | 112K | 189K | 188K | 169K | 101K | 183K |
| 銷售管理費用 | 898K | 1.0M | 955K | 822K | 1.1M | 871K | 1.1M | 1.0M | 1.0M | 925K | 849K | 944K |
| 營業利益 | −834K+519% | −1.3M+1915% | −575K-420% | −181K+1% | −135K-49% | −65K-28% | 180K-158% | −180K-21% | −266K | −91K | −309K | −228K |
| 營業利益率 | -31.2% | -55.1% | -19.8% | -5.5% | -3.7% | -2.0% | 4.6% | -5.7% | -9.2% | -2.9% | -10.6% | -7.3% |
| 稅後淨利 | −882K+449% | −1.3M+1096% | −431K-387% | −204K-13% | −161K+4% | −113K+3% | 150K-143% | −233K-11% | −154K | −109K | −349K | −263K |
| 淨利率 | -33.0% | -56.7% | -14.9% | -6.2% | -4.4% | -3.5% | 3.8% | -7.4% | -5.3% | -3.5% | -11.9% | -8.5% |
| 稀釋 EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 稀釋股數 | 529M | 528M | 527M | 528M | 527M | 524M | 523M | 523M | 520M | 518M | 518M | 518M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.2M | 1.3M | 1.7M | 1.7M | 1.9M | 1.6M | 2.4M | 2.2M | 2.4M | 2.7M | 2.9M | 3.3M |
| 應收帳款 | 1.2M | 1.3M | 1.4M | 2.0M | 1.7M | 1.7M | 1.5M | 1.1M | 1.4M | 1.5M | 1.4M | 1.3M |
| 存貨 | 645K | 832K | 875K | 1.0M | 671K | 724K | 845K | 699K | 934K | 927K | 741K | 701K |
| 總資產 | 16.6M | 17.2M | 17.8M | 17.8M | 17.5M | 17.6M | 16.7M | 15.9M | 16.8M | 16.9M | 16.2M | 15.8M |
| 有息負債 | – | – | 1.9M | – | – | – | – | – | – | 2.0M | – | – |
| 總負債 | 14.8M | 14.5M | 14.1M | 13.8M | 13.2M | 13.2M | 12.7M | 12.1M | 12.8M | 12.9M | 12.1M | 11.6M |
| 股東權益 | 1.9M | 2.6M | 3.7M | 4.1M | 4.3M | 4.3M | 4.0M | 3.8M | 4.0M | 4.0M | 4.1M | 4.3M |
| 負債比 | 88.6% | 84.6% | 79.3% | 77.0% | 75.6% | 75.3% | 75.8% | 76.0% | 76.0% | 76.1% | 74.8% | 73.2% |
| 淨現金(現金 − 有息負債) | – | – | −237K | – | – | – | – | – | – | 642K | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −72K+1315% | – | – | – | −5K | – | – | 412K | – | – | – |
| 資本支出 | – | 205K | 280K | 64K | 61K | 129K | 44K | 44K | 171K | −402K | 484K | 14K |
| 自由現金流 | – | −278K+107% | – | – | – | −134K | – | – | 242K | – | – | – |
| 折舊攤銷 | 107K | 110K | 103K | 101K | 101K | 98K | 101K | 99K | 101K | 88K | 87K | 88K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -11.7% | – | – | – | -4.1% | – | – | 8.3% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 13.1M
| Theranostics Products | 6.8M | 52.3% | -14.6% |
|---|---|---|---|
| Calibration Reference Products | 4.2M | 32.5% | +20.7% |
| Cobalt Products | 1.8M | 13.4% | -25.9% |
| Medical Device Products | 229K | 1.8% | +2544.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 13.1M | -6.0% | −908K | -6.9% | 0.00 | 86K |
| FY2024 | 13.9M | +13.3% | 9K | 0.1% | 0.00 | −82K |
| FY2023 | 12.3M | +9.7% | −869K | -7.1% | 0.00 | 434K |
| FY2022 | 11.2M | +15.7% | 303K | 2.7% | 0.00 | −1.6M |
| FY2021 | 9.7M | +3.2% | −902K | -9.3% | 0.00 | −367K |
| FY2020 | 9.4M | +4.6% | 2.2M | 23.5% | 0.01 | 1.1M |
| FY2019 | 9.0M | -13.6% | −1.5M | -17.0% | – | −262K |
| FY2018 | 10.4M | – | −845K | -8.1% | 0.00 | 11K |